secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2026-11-04T11:34:02+00:00
Accession:  0001193125-26-446150
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

CVS Health to split into two public companies: Aetna/Caremark solutions and 9,000-store CVS Pharmacy by H1 2028
--------------------------------------------------------------------------------

- Healthcare solutions company keeps the CVS Health name and will house Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health.
- CVS Pharmacy will comprise approximately 9,000 CVS pharmacies, mail pharmacy, MinuteClinic (including virtual care) and the Health100 technology services business.
- David Joyner, current Chairman and CEO, will chair and run the healthcare solutions company; Group President Prem Shah will be CEO of CVS Pharmacy.
- Separation targeted for completion in the first half of 2028, intended to be tax-free to CVS Health and shareholders; conditioned on Form 10 effectiveness and final board approval.
- Both companies expected to hold solid investment grade ratings and pay an attractive dividend; Goldman Sachs is lead financial advisor, Wachtell Lipton is legal counsel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000119312526446150/0001193125-26-446150-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000119312526446150/d148827d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-446150

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer